Ticker LaunchIPO · ATHA
LeonaBio, Inc.
Formerly Athira Pharma, Inc.; M3 Biotechnology, Inc.
LeonaBio, Inc. (ATHA) priced its initial public offering on Sep 18, 2020 at $17.00 per share, within its $15.00–$17.00 range, raising $204M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $523.9M. Goldman Sachs was lead-left underwriter, joined by Jefferies, Stifel and Citizens JMP.
At its 2020 IPO, Athira Pharma, Inc. (now LeonaBio, Inc.) was a late clinical-stage biopharmaceutical company developing small molecules to restore neuronal health and stop neurodegeneration by augmenting HGF/MET neuronal growth factor signaling.
- Status
- IPO
- Ticker
- ATHA
- Exchange
- Nasdaq Global Select
- Priced
- Sep 18, 2020
- IPO price
- $17.00
- Price range
- $15.00–$17.00
- Raised
- $204M
- Market cap at IPO price
- $523.9M
- First filed
- Aug 26, 2020
- Underwriters
- Goldman Sachs, Jefferies, Stifel and Citizens JMP
- Sector
- Biotech & pharma
- Country / state
- WA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Aug 26, 2020
- Latest amendment Sep 17, 2020
- Final prospectus (424B4) Sep 18, 2020
- All filings on EDGAR CIK 1620463
Other Biotech & pharma IPOs in 2020
- CalciMedica, Inc.GRAY · Sep 25, 2020 · $90M
- PMV Pharmaceuticals, Inc.PMVP · Sep 25, 2020 · $211.8M
- Prelude Therapeutics IncPRLD · Sep 25, 2020 · $158.2M
- COMPASS Pathways plcCMPS · Sep 21, 2020 · $127.5M
- Dyne Therapeutics, Inc.DYN · Sep 17, 2020 · $232.8M
- Metacrine, Inc.MTCR · Sep 16, 2020 · $85M